阿卡迪亞製藥公司
MX ˙ BMV ˙ US0042251084
SecurityMX:ACAD / ACADIA Pharmaceuticals Inc.
InstitutionCommonwealth Equity Services, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Commonwealth Equity Services, Llc closes position in ACAD / ACADIA Pharmaceuticals Inc.

On April 27, 2026 - Commonwealth Equity Services, Llc filed a 13F-HR form disclosing ownership of 0 shares of ACADIA Pharmaceuticals Inc. (MX:ACAD) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 14,705 shares of ACADIA Pharmaceuticals Inc.. This represents a change in shares of -100.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 0 -14,705 -100.00 0 -100.00
2026-02-12 2025-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 14,705 1,004 7.33 393 0.0005
2025-10-22 2025-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 13,701 -30,048 -68.68 0 0.0004
2025-08-06 2025-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 43,749 166 0.38 1 0.0012
2025-05-09 2025-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 43,583 242 0.56 1 0.0010
2025-02-10 2024-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 43,341 28,395 189.98 1 0.0012
2024-10-18 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 14,946 176 1.19 0 0.0003
2024-07-31 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 14,770 778 5.56 0 0.0004
2024-04-29 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 13,992 -233 -1.64 0 0.0004
2024-02-06 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 14,225 620 4.56 0 0.0008
2023-10-23 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 13,605 -850 -5.88 0 0.0006
2023-08-10 2023-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 14,455 248 1.75 0 0.0007
2023-05-11 2023-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 14,207 277 1.99 0 0.0006
2023-02-07 2022-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 13,930 865 6.62 0 -100.00 0.0005
2022-11-14 2022-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 13,065 -458 -3.39 213 12.11 0.0005
2022-07-19 2022-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 13,523 97 0.72 190 -41.54 0.0005
2022-05-04 2022-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 13,426 -627 -4.46 325 -0.91 0.0007
2022-01-31 2021-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 14,053 -319 -2.22 328 37.82 0.0007
2021-10-29 2021-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 14,372 -1,141 -7.36 238 -37.04 0.0006
2021-08-11 2021-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 15,513 -150 -0.96 378 -6.44 0.0010
2021-05-04 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 15,663 -135 -0.85 404 -52.13 0.0011
2021-02-11 2020-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 15,798 393 2.55 844 32.91 0.0025
2020-11-05 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 15,405 1,239 8.75 635 -7.43 0.0022
2020-08-12 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 14,166 -575 -3.90 686 10.29 0.0026
2020-05-11 2020-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 14,741 160 1.10 622 -0.16 0.0029
2020-02-05 2019-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 14,581 1,650 12.76 623 33.98 0.0024
2019-10-30 2019-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 12,931 -846 -6.14 465 26.36 0.0020
2019-07-19 2019-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 13,777 -69 -0.50 368 -0.81 0.0016
2019-05-13 2019-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 13,846 -110 -0.79 371 64.89 0.0017
2019-02-11 2018-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 13,956 -14 -0.10 225 -22.41 0.0012
2018-11-06 2018-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 13,970 503 3.74 290 40.78 0.0014
2018-07-31 2018-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 13,467 -523 -3.74 206 -34.39 0.0011
2018-05-14 2018-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 13,990 13,990 314 0.0017
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.